Procainamide Hydrochloride (Nexus Pharmaceuticals Inc)


Welcome to the PulseAid listing for the Procainamide Hydrochloride drug offered from Nexus Pharmaceuticals Inc. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Nexus Pharmaceuticals Inc
NON-PROPRIETARY NAME: Procainamide Hydrochloride
SUBSTANCE NAME: PROCAINAMIDE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-10-18
END MARKETING DATE: 0000-00-00


Procainamide Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionProcainamide Hydrochloride from Nexus Pharmaceuticals Inc
LABELER NAME: Nexus Pharmaceuticals Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 1000(mg/1)
START MARKETING DATE: 2017-10-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 14789-900_c500fb74-4285-4756-aa0d-c6da775f72b4
PRODUCT NDC: 14789-900
APPLICATION NUMBER: ANDA206332

Other PROCAINAMIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthProcainamide Hydrochloride
Hospira, Inc.Procainamide Hydrochloride
International Medication Systems, LimitedProcainamide Hydrochloride
McKesson Packaging Services Business Unit of McKesson CorporationProcainamide Hydrochloride
Nexus Pharmaceuticals IncProcainamide Hydrochloride